Title of Collaborative Activity:
Newborn Drug Development Planning committee
Description of Collaborative Activity:
Primary responsibility for administering, contracting, and monitoring studies to develop Investigational New Drug (IND) application data for potential label modification.
Type of Collaborative Activity:
Other
Year the Collaborative Activity Originated:
2011
NIH Participating Institutes/Centers/Office of the Director:
NHLBI, NICHD, NLM
HHS Agency Collaborators on this Activity:
FDA